Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women

Obesity (Silver Spring). 2009 Jun;17(6):1124-8. doi: 10.1038/oby.2008.665. Epub 2009 Feb 5.

Abstract

The aim of the study was to evaluate human plasma circulating levels of adipocyte fatty acid-binding protein (A-FABP) and its relationship with proinflammatory adipocytokines and insulin resistance in a severely obese cohort, before and 1 year after a surgical gastric bypass. Plasmatic levels of A-FABP were measured in 77 morbid-obese women before and 1 year after bariatric surgery. Anthropometrical parameters and body composition by bioelectrical impedance analysis were determined. Circulating levels of soluble tumor necrosis factor receptor 2 (sTNFR2), Interleukin 18 (IL-18), adiponectin, and high-sensitive C-reactive protein (hsCRP) were also analyzed. Insulin resistance by homeostasis model assessment of insulin resistance (HOMA-IR) index was calculated. After massive weight loss, A-FABP plasmatic levels decreased significantly [7.6 (8.9) vs. 4.3 (5.1); P<0,001] but no association with circulating adipokines or proinflammatory cytokines, both at the beginning and at the end of follow-up, was observed. A decrease in sTNFR2, IL-18, hsCRP, and an increase in adiponectin levels (P<0.001 in all cases) were observed after the gastric bypass. HOMA-IR index improved 1 year after surgery and after multiple regression analysis remained associated with A-FABP after controlling for confounding variables (beta=0.322, P=0.014; R2 for the model 0.281). In morbid-obese women, plasma A-FABP concentrations were dramatically reduced after gastric bypass surgery. After weight loss this protein contributed to HOMA-IR index independently of proinflammatory/antinflammatory cytokine profile. Further studies are warranted to elucidate the role of A-FABP in the pathogenesis of insulin resistance in morbid obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood
  • Adult
  • Biomarkers / blood
  • C-Reactive Protein / metabolism
  • Fatty Acid-Binding Proteins / blood*
  • Female
  • Gastric Bypass
  • Humans
  • Insulin Resistance*
  • Interleukin-18 / blood
  • Middle Aged
  • Obesity, Morbid / blood*
  • Obesity, Morbid / physiopathology
  • Obesity, Morbid / surgery
  • Receptors, Tumor Necrosis Factor, Type II / blood
  • Time Factors
  • Treatment Outcome
  • Weight Loss

Substances

  • ADIPOQ protein, human
  • Adiponectin
  • Biomarkers
  • FABP4 protein, human
  • Fatty Acid-Binding Proteins
  • Interleukin-18
  • Receptors, Tumor Necrosis Factor, Type II
  • C-Reactive Protein